New study to combat the most common form of liver cancer

October 12, 2012

Scientists at the University of Southampton are to investigate the best way to use natural killer cells (NK) to target the most common form of liver cancer.

are able to directly kill cancer in the body and stimulate other cells in the immune system to help attack cancer.

At the moment, NK cells, and the chemicals that manipulate them, are being used to treat a variety of different cancers, mainly cancers of the blood.

However there is growing evidence that these cells could be used to create an to hepatocellular cancer (HCC) cells and be used to kill them.

HCC is the most common form of and is mainly caused by cirrhosis of the liver – where the liver has become scarred as a result of damage over a long period of time.

Funded by the British Liver Trust, researchers at the University of Southampton will investigate how to manipulate NK cells to attack HCC cells.

The University's Salim Khakoo, Professor of and Aymen Al-Shamkhani, Professor in Immunology will be leading the study.

Professor Khakoo explains: "Hepatocellular cancer accounts for 90 per cent of all primary liver cancers and is an extremely difficult condition to treat. At this early stage of the study we aim to create a method to form the basis for a clinical trial to use NK cells to treat HCC.

"To do this we will study patients with HCC and then use three different stimuli to activate NK cells. These different include a chemical stimulant of NK cells and antibodies that target molecules on the surface of the NK cells. By trying different combinations of these chemicals and antibodies together, we will be able to develop an optimal method to use them for ."

When the team has developed a successful method for stimulating the NK cells, tests will be carried out to determine the best way to use them for an anti-cancer effect.

Andrew Langford, Chief Executive of the British Liver Trust commented "The British Liver Trust is delighted to fund what we hope will be invaluable research for new treatment of liver cancer. Unfortunately, of the big five killer diseases, deaths from liver cancer is the only one that continues to increase and the average age at which people die of a liver disease is now 59 and this gets lower each year; consequently, any research into new treatments offers hope that we can treat those that have liver cancer more effectively."

Explore further: Research in fish provides new clues about deadly form of liver cancer

Related Stories

Research in fish provides new clues about deadly form of liver cancer

July 5, 2011
Hepatocellular carcinoma (HCC), the most common type of liver cancer, is a leading cause of cancer-related deaths worldwide. Although there are several treatment options available, they are largely unsuccessful because the ...

miR-122: Loss of tiny liver molecule might lead to liver cancer

July 23, 2012
A new study shows that loss of a small RNA molecule in liver cells might cause liver cancer and that restoring the molecule might slow tumor growth and offer a new way to treat the disease.

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.